» Articles » PMID: 32604013

Increase in the Risk of Type 2 Diabetes During Lockdown for the COVID19 Pandemic in India: A Cohort Analysis

Overview
Specialty Endocrinology
Date 2020 Jul 1
PMID 32604013
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Material Methods: Baseline demographic and clinical data from 100 apparently non-diabetic household members (related or unrelated) of patients with type 2 diabetes mellitus were collected until 49 days of lockdown and analyzed using the XL-STAT statistical software. A two-pronged analytical strategy was employed. First, the metabolic risk profile related to age, sex, weight, family history, and exercise pattern was analyzed. This was followed by an assessment of the risk of developing type 2 diabetes using an established risk assessment engine.

Results: There was a trend towards weight gain seen in 40% of the cohort, with 16% of the population experiencing a 2.1-5 kg weight increment. When all the risk parameters were analyzed together using the ADA risk engine, there was an increase in the ADA diabetes risk score in 7% of the population, with 6.66% in the high-risk group. There was a further increase in weight among 3% of the population who were already obese at baseline.

Conclusion: We show an increased risk of T2MD consequent to weight gain during 49 days of lockdown in India.

Citing Articles

Predicting Type 2 diabetes onset age using machine learning: A case study in KSA.

Al-Hussein F, Tafakori L, Abdollahian M, Al-Shali K, Al-Hejin A PLoS One. 2025; 20(2):e0318484.

PMID: 39932985 PMC: 11813135. DOI: 10.1371/journal.pone.0318484.


Mediterranean Diet adherence, physical activity level, and quality of life in patients affected by thyroid diseases: Comparison between pre- and post-lockdown assessment.

Corrias S, Fosci M, Galletta M, Boi F, Baghino G, Oppo A J Public Health Res. 2024; 13(4):22799036241291270.

PMID: 39493705 PMC: 11528575. DOI: 10.1177/22799036241291270.


The Implications of the Pandemic with Covid-19 in the Glycemic Control of People with Type 2 Diabetes.

Gherbon A, Frandes M, Nicula-Neagu M, Timar R, Timar B Diabetes Metab Syndr Obes. 2023; 16:4109-4118.

PMID: 38116018 PMC: 10729828. DOI: 10.2147/DMSO.S434990.


The impact of the COVID-19 pandemic in diabetes and dyslipidemia management in a Spanish region: a retrospective study of the Aragon population.

Mateo-Gallego R, Gracia-Rubio I, Garza M, Cebollada A, Perez-Calahorra S, Bayona-Sanchez A Front Med (Lausanne). 2023; 10:1191026.

PMID: 37484851 PMC: 10359133. DOI: 10.3389/fmed.2023.1191026.


Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges.

Vaishya R, Misra A, Vaish A, Singh S J Diabetes. 2023; 16(5):e13427.

PMID: 37292055 PMC: 11070841. DOI: 10.1111/1753-0407.13427.


References
1.
Bang H, Edwards A, Bomback A, Ballantyne C, Brillon D, Callahan M . Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009; 151(11):775-83. PMC: 3633111. DOI: 10.7326/0003-4819-151-11-200912010-00005. View

2.
Anderson R, Heesterbeek H, Klinkenberg D, Hollingsworth T . How will country-based mitigation measures influence the course of the COVID-19 epidemic?. Lancet. 2020; 395(10228):931-934. PMC: 7158572. DOI: 10.1016/S0140-6736(20)30567-5. View

3.
Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C . The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020; 78:185-193. PMC: 7162753. DOI: 10.1016/j.ijsu.2020.04.018. View

4.
Ford E, Williamson D, Liu S . Weight change and diabetes incidence: findings from a national cohort of US adults. Am J Epidemiol. 1997; 146(3):214-22. DOI: 10.1093/oxfordjournals.aje.a009256. View

5.
Fruhbeck G, Baker J, Busetto L, Dicker D, Goossens G, Halford J . European Association for the Study of Obesity Position Statement on the Global COVID-19 Pandemic. Obes Facts. 2020; 13(2):292-296. PMC: 7250342. DOI: 10.1159/000508082. View